Australia markets closed

Prescient Therapeutics Limited (PTX.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.05900.0000 (0.00%)
At close: 04:10PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) 47.51M
Enterprise value 29.08M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.10
Enterprise value/revenue -137.24
Enterprise value/EBITDA -2.52

Trading information

Stock price history

Beta (5Y monthly) 1.10
52-week change 3-35.87%
S&P500 52-week change 320.07%
52-week high 30.1050
52-week low 30.0440
50-day moving average 30.0531
200-day moving average 30.0632

Share statistics

Avg vol (3-month) 31.12M
Avg vol (10-day) 3645.92k
Shares outstanding 5805.32M
Implied shares outstanding 6805.32M
Float 8688.51M
% held by insiders 114.51%
% held by institutions 10.17%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 302 Dec 2014

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin -248.74%
Operating margin (ttm)-205.42%

Management effectiveness

Return on assets (ttm)-20.79%
Return on equity (ttm)-32.67%

Income statement

Revenue (ttm)3.11M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)54.60%
Gross profit (ttm)N/A
Net income avi to common (ttm)-7.74M
Diluted EPS (ttm)-0.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)18.44M
Total cash per share (mrq)0.02
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)10.26
Book value per share (mrq)0.03

Cash flow statement

Operating cash flow (ttm)-7.67M
Levered free cash flow (ttm)-5.28M